Biolegend, 135014, PE/Cyanine7 anti-mouse CD127 (IL-7Rα) Antibody, 100μg

CD127 is a 60-90 kD type I transmembrane glycoprotein also known as IL-7 receptor α chain or IL-7Rα. It forms a heterodimer with the common γ chain (γc or CD132) which is shared with the receptors for IL-2, IL-4, IL-9, IL-13, IL-15, and IL-21. CD127 is expressed on immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, and bone marrow stromal cells. CD127 has been reported to be an useful marker for identifying memory and effector T cells. The ligation of IL-7 with its receptor is important for stimulation of mature and immature T cells as well as immature B cells proliferation and development.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: IL-7Ra-IgG1 fusion protein
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone A7R34 is able to completely block the binding of clone S18006K to IL-7Rα. It does not block SB/199.
Application References(PubMed link indicates BioLegend citation): Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125. Hashi H, et al. 2001. J. Immunol. 166:3702. Taylor R, et al. 2007. J. Immunol. 178:5659. Mazzon C, et al. 2011. Blood. 118:2733. PubMed Jin J, et al. 2011. J. Immunol. doi:10.4049/jimmunol.1001238. PubMed
Product Citations: Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed Zander R, et al. 2022. Elife. 11:. PubMed Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed Shallberg LA, et al. 2022. PLoS Pathog. 18:e1010296. PubMed Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed Giannou AD, et al. 2023. Immunity. 56:125. PubMed Gonçalves R, et al. 2023. iScience. 26:105972. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Feng J, et al. 2022. Immunity. 55:405. PubMed Zander R, et al. 2022. Immunity. 55:475. PubMed Ye B, et al. 2022. Cell Mol Immunol. 19:619. PubMed Page N, et al. 2018. Immunity. 48:937. PubMed Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed Pokrovskii M, et al. 2019. Immunity. 51:185. PubMed Oda SK, et al. 2020. J Exp Med. 217: . PubMed Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed Zhang B, et al. 2022. J Exp Med. 219:. PubMed Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed Oka Y, et al. 2020. Sci Adv. 6:. PubMed Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed Olguín JE, et al. 2018. J Cancer. 9:239. PubMed Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed Lehrke MJ, et al. 2021. Elife. 10:. PubMed Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed Zhong C, et al. 2020. Immunity. 52(1):83-95.e4.. PubMed Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed Goc J, et al. 2021. Cell. 184:5015. PubMed Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed Zander R, et al. 2020. Immunity. 51(6):1028-1042.e4.. PubMed Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
RRID: AB_1937266 (BioLegend Cat. No. 135013) AB_1937265 (BioLegend Cat. No. 135014)
Structure: Type I transmembrane glycoprotein, associate with CD132, 60-90 kD
Distribution: Immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, bone marrow stromal cells
Function: T cell and immature B cell proliferation and development
Ligand/Receptor: IL-7
Cell Type: B cells, T cells, Thymocytes
Biology Area: Immunology
Molecular Family: CD Molecules, Cytokine/Chemokine Receptors
Antigen References: 1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125. 2. Okuno Y, et al. 2001. P. Natl. Acad. Sci. USA 99:6246. 3. Pillai M, et al. 2004. Leukemia Lymphoma 45:2403.
Gene ID: 16197
UniProt: View information about CD127 on UniProt.org
Clone: A7R34
Regulatory Status: RUO
Other Names: IL-7 receptor α chain, IL-7Rα
Isotype: Rat IgG2a, κ